Aaron A Westphal, MD | |
169 Birch St, Boone, NC 28607-5069 | |
(828) 264-4453 | |
(828) 264-4941 |
Full Name | Aaron A Westphal |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 22 Years |
Location | 169 Birch St, Boone, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164479960 | NPI | - | NPPES |
036115339 | Medicaid | IL | |
8901404 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ND0101X | Dermatology - Mohs-micrographic Surgery | 2007-00217 (North Carolina) | Primary |
207ND0101X | Dermatology - Mohs-micrographic Surgery | 036-115339 (Illinois) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Boone Dermatology Clinic | 8224062666 | 11 |
News Archive
During a coronary bypass procedure, surgeons redirect blood flow using an autologous bypass graft, most often derived from the patient's own veins. However, in certain situations where the patient does not have a suitable vein, surgeons must rely on synthetic vascular grafts which, while life-saving, are more prone to clot formation that eventually obstructs the graft.
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
A University of Manchester scientist has revealed the mechanism that binds skin cells tightly together, which he believes will lead to new treatments for painful and debilitating skin diseases and also lethal heart defects.
The Health 2.0 Developer Challenge, an initiative designed to stimulate new innovative application development and data use, announces its four newest challenges which include prize money of over $15,000.
EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).
› Verified 7 days ago
Entity Name | Boone Dermatology Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417913260 PECOS PAC ID: 8224062666 Enrollment ID: O20050924000034 |
News Archive
During a coronary bypass procedure, surgeons redirect blood flow using an autologous bypass graft, most often derived from the patient's own veins. However, in certain situations where the patient does not have a suitable vein, surgeons must rely on synthetic vascular grafts which, while life-saving, are more prone to clot formation that eventually obstructs the graft.
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
A University of Manchester scientist has revealed the mechanism that binds skin cells tightly together, which he believes will lead to new treatments for painful and debilitating skin diseases and also lethal heart defects.
The Health 2.0 Developer Challenge, an initiative designed to stimulate new innovative application development and data use, announces its four newest challenges which include prize money of over $15,000.
EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Aaron A Westphal, MD 169 Birch St, Boone, NC 28607-5069 Ph: (828) 264-4453 | Aaron A Westphal, MD 169 Birch St, Boone, NC 28607-5069 Ph: (828) 264-4453 |
News Archive
During a coronary bypass procedure, surgeons redirect blood flow using an autologous bypass graft, most often derived from the patient's own veins. However, in certain situations where the patient does not have a suitable vein, surgeons must rely on synthetic vascular grafts which, while life-saving, are more prone to clot formation that eventually obstructs the graft.
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
A University of Manchester scientist has revealed the mechanism that binds skin cells tightly together, which he believes will lead to new treatments for painful and debilitating skin diseases and also lethal heart defects.
The Health 2.0 Developer Challenge, an initiative designed to stimulate new innovative application development and data use, announces its four newest challenges which include prize money of over $15,000.
EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).
› Verified 7 days ago
Ronald J Stanley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 169 Birch St, Boone, NC 28607 Phone: 828-264-4553 Fax: 828-262-3649 | |
Margaret K Sparks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 381 Meadowview Dr, Boone, NC 28607 Phone: 828-263-0067 Fax: 828-263-0203 | |
Mr. David Stanton Whittaker Jr., MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 169 Birch St, Boone, NC 28607 Phone: 828-264-4553 Fax: 828-262-3649 | |
Brett Summey Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 169 Birch St, Boone, NC 28607 Phone: 828-264-4553 Fax: 828-264-4941 | |
Dr. Brittain Hammill Tulbert, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 169 Birch St, Boone, NC 28607 Phone: 828-264-4553 |